Rachael DiSantostefano, PhD
Director, Benefit-Risk/Epidemiology
Janssen R&D
1125 Trenton-Harbourton Road
Titusville,
NJ
USA
08560
Biographical Sketch: Experienced research scientist with expertise in epidemiology, biostatistics, and health outcomes across the non-profit, CRO, and pharmaceutical industries. 22 years of broad drug development experience; 12 years of supervisory experience; Strong quantitative background; Cross-functional matrix team leader. Develops, designs and implement studies based on evidence needs, including prospective or retrospective observational studies to support benefit-risk assessment and epidemiology.
Specialties/key words: benefit-risk assessment, discrete choice experiments, epidemiology, pharmacoepidemiology, data analysis, project management, respiratory, process improvement, REMS, risk management plans, real world evidence (RWE), real world data strategy, non-interventional studies, observational studies.
Papers:
5N-3
HOW HETEROGENEOUS ARE PREFERENCES FOR DELAYING ONSET OF ALZHEIMER'S DISEASE: IT DEPENDS ON HOW YOU LOOK